Sfoglia per RIVISTA
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
Collezione AOU San Luigi di Orbassano

  

Items : 31

Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated Non-Small-Cell Lung Cancer with brain metastases: a meta-analysis and systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Oct 30:104540. doi: 10.1016/j.critrevonc.2024.104540.

2024
AOU San Luigi di Orbassano

Nepote A; Poletto S; Bertaglia V; Carnio S; Piumatti C; Lanzetta C; Cantale O; Saba G; Bironzo P; Novello S; Tralongo AC;

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13

2024
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano

Di Maio M; Novello S; Sperone P; Vellani G; Vignani F; Dionisio R; Paratore C; Valsecchi AA; Ferrari G;

Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Feb;194:104243. doi: 10.1016/j.critrevonc.2023.104243. Epub 2023 Dec 20

2024
AOU San Luigi di Orbassano

Russano M; Petrini I; Metro G; Catino A; Bonanno L; Bennati C; Bironzo P; Russo GL; Passaro A;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24

2023
AO Ordine Mauriziano
ASL Asti
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Di Maio M; Audisio A; Brusa F; Ungaro A; Audisio M; Samuelly A; Turco F; Di Stefano RF; Tucci M; Delcuratolo MD;

Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103954. doi: 10.1016/j.critrevonc.2023.103954. Epub 2023 Mar 5.

2023
ASL Torino 3
AOU San Luigi di Orbassano

Scartozzi M; Tampellini M; Denaro N; Manunta S; Aiello MM; Solinas C; Morelli AM; Bertaglia V; Novello S;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Audisio M; Tucci M;

Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103525. doi: 10.1016/j.critrevonc.2021.103525. Epub 2021 Nov 20

2022
ASL Torino 4
AOU San Luigi di Orbassano

Russo A; Righi D; Pasini S; Perrone G; Pagni F; Novello S; Mastrilli F; Gristina V; Galvano A; Barberis M; Baggi A; Troncone G; Pisapia P; Pepe F; Malapelle U;

Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103536. doi: 10.1016/j.critrevonc.2021.103536. Epub 2021 Nov 18

2022
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano

Rocco D; Migliorino MR; Parra HS; Pagni F; Seminati D; Passaro A; Tiseo M; Cortinovis D; Galetta D; Belluomini L; Pepe F; Pisapia P; Passiglia F; Reale ML; Malapelle U; Pilotto S; Troncone G; Novello S;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19

2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Scagliotti GV; Carnio S; Buffoni L; Passiglia F; Zichi C; Capelletto E; Reale ML; Artusio E; Olmetto E; Bertaglia V; Paratore C; Bungaro M; Curcio H; De Luca E; Tagliamento M; Audisio M; Rapetti SG; Bironzo P; Pignataro D; Di Maio M;

The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103602. doi: 10.1016/j.critrevonc.2022.103602. Epub 2022 Jan 19

2022
AOU San Luigi di Orbassano

Schmidinger M; Gori V; Novello S; Scavone C; Cucchiara F; Passiglia F; Del Re M; Tabbò F; Capuano A; Fogli S; Danesi R;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Buttigliero C; Di Maio M; Scagliotti GV; Di Stefano RF; Turco F; Tucci M; Pisano C;

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27

2021
AOU San Luigi di Orbassano

Passiglia F; Sperone P; Capelletto E; Artusio E; Carnio S; Di Stefano RF; Rapetti S; Audisio M; Bungaro M; Tabbò F; Leone G; Mariniello A; Palesandro E; Bironzo P; Reale ML; Bertaglia V; Novello S;

Exploring the role of respiratory microbiome in lung cancer: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Aug;164:103404. doi: 10.1016/j.critrevonc.2021.103404. Epub 2021 Jun 29

2021
ASL Asti
AOU San Luigi di Orbassano

Novello S; Galetta D; Menis J; Tiseo M; Facchinetti F; Bironzo P; Sartori G; Russano M; Rinaldi S; Prelaj A; Pignataro D; Montrone M; Meacci F; Bianconi M; Di Noia V; Mazzotta M; Pilotto S; Perrone F; Belluomini L;

Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103300. doi: 10.1016/j.critrevonc.2021.103300. Epub 2021 Mar 17

2021
AOU San Luigi di Orbassano

De Luca C; Russo G; Reale ML; Tabbò F; Belluomini L; Bironzo P; Listì A; Righi L; Pisapia P; Pepe F; Passiglia F; Pilotto S; Malapelle U; Novello S; Troncone G;

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Scagliotti GV; Aglietta M; Novello S; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; De Luca E; Zichi C; Marandino L; Lombardi P; Di Maio M;

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28

2020
AOU San Luigi di Orbassano

Rossi G; Ramella S; Passaro A; Menis J; Malapelle U; Franchina T; Ferrara R; Del Re M; Bertolaccini L; Facchinetti F; Pilotto S; Passiglia F; Trisolini R; Novello S;

Double immune checkpoint blockade in advanced NSCLC. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102980. doi: 10.1016/j.critrevonc.2020.102980. Epub 2020 May 19

2020
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Mariniello A; Ramalingam SS;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24

2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Di Maio M; Tucci M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Pisano C; Di Stefano RF; Buttigliero C; Leone G;

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102862. doi: 10.1016/j.critrevonc.2019.102862. Epub 2020 Jan 25

2020
AOU San Luigi di Orbassano

Rossi G; Ramella S; Pilotto S; Passaro A; Menis J; Franchina T; Malapelle U; Ferrara R; Facchinetti F; Del Re M; Passiglia F; Bertolaccini L; Trisolini R; Novello S;

Corrigendum to "Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario" [Crit. Rev. Oncol./Hematol. 122 (February) (2018) 150-156]. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:158. doi: 10.1016/j.critrevonc.2018.06.018. Epub 2018 Nov 2.

2019
AOU San Luigi di Orbassano

Buffoni L; Novello S; Robinson T; Tabbò F; Addeo A;

Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.

2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Sperone P; La Salvia A; Muratori L;

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 1

2018
AOU San Luigi di Orbassano

Di Nunno V; De Luca E; Buttigliero C; Tucci M; Vignani F; Gatto L; Zichi C; Ardizzoni A; Di Maio M; Massari F;

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baratelli C; Zichi C; Di Maio M; Brizzi MP; Sonetto C; Scagliotti GV; Tampellini M;

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:150-156. doi: 10.1016/j.critrevonc.2017.12.015. Epub 2017 Dec 3

2018
AOU San Luigi di Orbassano

Addeo A; Tabbò F; Robinson T; Buffoni L; Novello S;

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14.

2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Montefusco V; Palumbo A; Ribolla R; Siniscalchi A; Patriarca F; Pezzatti S; De Sabbata G; Di Renzo N; Rizzi R; Gamberi B; Baldini L; Guglielmelli T; Gilestro M; Catalano L; Marcatti M; Spada S; Petrucci MT; Ria R; Offidani M; De Paoli L; Conticello C; D'Agostino M; Nagler A; Boccadoro M; Gay F;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.

2018
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;

Chemical shift and diffusion-weighted magnetic resonance imaging of the anterior mediastinum in oncology: Current clinical applications in qualitative and quantitative assessment. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2016 Feb;98:335-57. doi: 10.1016/j.critrevonc.2015.11.012. Epub 2015 Nov 23.

2016
AOU San Luigi di Orbassano

Priola AM; Gned D; Veltri A; Priola SM;

Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: a review of existing evidence. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2012 Aug;83(2):208-15. doi: 10.1016/j.critrevonc.2011.09.009. Epub 2011 Nov

2012
AOU San Luigi di Orbassano

Novello S; Giaj Levra M; Vavalà T;

Optimizing treatment for men with advanced prostate cancer: Expert recommendations and the multidisciplinary approach in Critical Reviews in Oncology/Hematology

2008
AOU San Luigi di Orbassano

Fitzpatrick JM; Anderson J; Sternberg CN; Fleshner N; Fizazi K; Rébillard X; Dogliotti L; Conti G; Turesson I; James N; Heidenreich A; Solsona E; Guillem V; Herchenhorn D; Moul J; van Moorselaar J; Coetzee LJE; Wilson A; Bamias A; De Wit R; Chrisofos M;

Proteasome inhibitors in lung cancer. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2006 Jun;58(3):177-89. doi: 10.1016/j.critrevonc.2005.12.001. Epub 2006 Jan

2006
AOU San Luigi di Orbassano

Scagliotti G;

Management of bone metastases in cancer: a review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2005 Dec;56(3):365-78. doi: 10.1016/j.critrevonc.2005.03.011. Epub 2005 Jun

2005
AOU San Luigi di Orbassano

Selvaggi G; Scagliotti GV;